Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 372 |
---|---|
Genomic Coordinate (GRCh38) | g.22114495_22114499delinsTTTACAT |
Variant | c.1211_1215delinsTTTACAT |
Variant Start Position | 1211 |
Location | Exon 11 |
Amino Acid Change | p.Asp404Valfs*5 |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
Variant Type | Small insertion |
PMID | 26107949, 34806794 |
Article Count | 2 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pvs1, ps2, ppc_het |
ACMG Explanations | pvs1: This is a loss of function variant. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | ppc_het, ps2 |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22132613-ACAAA-TTTACAT |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |